Literature DB >> 9396050

Adrenomedullin binds with high affinity, elevates cyclic AMP, and stimulates c-fos mRNA in C6 glioma cells.

T W Moody1, M J Miller, A Mártinez, E Unsworth, F Cuttitta.   

Abstract

The effects of adrenomedullin (ADM) on C6 glioma cells were investigated. [125I]ADM bound with high affinity (Kd = 24 nM) to a single class of sites (Bmax = 36,000/cell) in C6 cells. Specific [125I]ADM binding was inhibited with high affinity by ADM (IC50 value of 10 nM) but not ADM(22-52) or pro-adrenomedullin N-terminal 20 peptide (PAMP). By RT-PCR, ADM receptors were detected in C6 cells. ADM elevated cAMP (ED50 value of 10 nM) whereas PAMP and ADM(22-52) did not. ADM stimulated transiently c-fos mRNA in a concentration-dependent manner. Monoclonal antibody G6, which neutralizes ADM, significantly inhibited C6 proliferation and decreased the ability of ADM to elevate c-fos mRNA. These data suggest that ADM is a regulatory peptide of C6 cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9396050     DOI: 10.1016/s0196-9781(97)00179-4

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  3 in total

1.  Neutralization of adrenomedullin inhibits the growth of human glioblastoma cell lines in vitro and suppresses tumor xenograft growth in vivo.

Authors:  L'Houcine Ouafik; Samantha Sauze; Françoise Boudouresque; Olivier Chinot; Christine Delfino; Frédéric Fina; Vincent Vuaroqueaux; Christophe Dussert; Jacqueline Palmari; Henri Dufour; François Grisoli; Pierre Casellas; Nils Brünner; Pierre-Marie Martin
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

2.  The Role of Adrenomedullin in Cardiovascular Response to Exercise - A Review.

Authors:  Krzysztof Krzeminski
Journal:  J Hum Kinet       Date:  2016-10-14       Impact factor: 2.193

3.  Calcitonin gene-related peptide induces the histone H3 lysine 9 acetylation in astrocytes associated with neuroinflammation in rats with neuropathic pain.

Authors:  Chenyan Sun; Qi An; Ruidi Li; Shuhui Chen; Xinpei Gu; Shuhong An; Zhaojin Wang
Journal:  CNS Neurosci Ther       Date:  2021-08-16       Impact factor: 5.243

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.